Skip to content

S. 2658 · 119th Congress (2025–2027)

Medication Affordability and Patent Integrity Act

This bill requires applicants seeking approval of a drug or licensure of a biological product to submit certain information about relevant patents to both the Food and Drug Administration (FDA) and the U.S. Patent and Trademark Office (USPTO).

Specifically, the bill requires applicants to make certifications and disclosures related to each applicable patent on a proposed drug or biological product. An applicable patent is a patent or patent application held or sought by the applicant for the drug or biological product (including a formulation or composition, method of use, or method of manufacturing).

For each applicable patent, an applicant must submit to the USPTO any information material to patentability that the applicant submitted to the FDA and any information provided by the FDA in response. The applicant must certify that this submission is complete and consistent with the information the applicant provided to the FDA.

Further, for each applicable patent, an applicant must certify that certain information submitted to the FDA is consistent with information the applicant provided to the USPTO. This is specific to statements or characterizations that are material to patentability and related to (1) an applicable patent (including a statement or characterization of relevant publicly known information), or (2) analytical data included in a new drug or biological product application.

The bill establishes a defense to a patent infringement action if the owner of an applicable patent negligently or intentionally failed to make the disclosures required by these provisions.

Show official title

A bill to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.

Reported

This bill’s path

This is S. 2658’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

Sponsor
Sen. Margaret Wood Hassan (D-NH)
Cosponsors
1 cosponsor

1 original · 0 later

  1. Sen. Josh Hawley (R-MO)· Original · Aug 1, 2025
Policy area
Health
Subjects
  • Drug safety, medical device, and laboratory regulation
  • Inflation and prices
  • Intellectual property
  • Manufacturing
  • Prescription drugs

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest
    ▸ 3 committee actions · Aug 1, 2025 – Jul 28, 2026
    1. Referred to committee

      Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

      Sources
    2. Ordered reported

      Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

      Sources
    3. Reported by committee

      Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

      Sources

Committees

  1. SenateHealth, Education, Labor, and PensionsReferred Aug 1, 2025 · Hearings by (full committee) Mar 19, 2026 · Markup Jun 17, 2026 · Reported Jul 28, 2026
    1. Jun 17, 2026 · Open business meeting

    2. Mar 19, 2026 · Meeting

      Member Day to examine S.297, to amend title XXVII of the Public Health Service Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for prostate cancer screenings without the imposition of cost-sharing requirements, S.380, to improve obstetric emergency care, S.547, to require the Secretary of Health and Human Services and the Secretary of Labor to conduct a study and issue a report on grant programs to support the nursing workforce, S.846, to implement or strengthen programs that increase the supply of quality child care services by enhancing the wages of child care workers, S.864, to amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, S.880, to amend the Higher Education Act of 1965 to prohibit institutions of higher education participating in Federal student assistance programs from giving preferential treatment in the admissions process to legacy students or donors, S.942, to amend the Higher Education Act of 1965 to provide for interest-free deferment on student loans for borrowers serving in a medical or dental internship or residency program, S.1269, to promote United States leadership in technical standards by directing the National Institute of Standards and Technology and the Department of State to take certain actions to encourage and enable United States participation in developing standards and specifications for artificial intelligence and other critical and emerging technologies, S.1380, to amend the Public Health Service Act to authorize a loan repayment program to encourage specialty medicine physicians to serve in rural communities experiencing a shortage of specialty medicine physicians, S.1387, to authorize the National Biotechnology Initiative, S.1482, to amend the Public Health Service Act to support and stabilize the existing nursing workforce, establish programs to increase the number of nurses, S.1677, to provide health insurance benefits for outpatient and inpatient items and services related to the diagnosis and treatment of a congenital anomaly or birth defect, S.1756, to amend the Public Health Service Act to prohibit discrimination against health care entities that do not participate in abortion, and to strengthen implementation and enforcement of Federal conscience laws, S.1784, to improve coordination of Federal efforts to identify and mitigate health and national security risks through maintaining a list of essential medicines, conducting a risk assessment of essential medicine supply chains, and creating a monitoring system to map essential medicine supply chains using data analytics, S.1813, to amend the Internal Revenue Code of 1986 to allow a credit against tax for charitable donations for the creation or expansion of charter schools, S.1830, to clarify that agencies of the Department of Health and Human Services do not have the authority to regulate the practice of medicine, S.2287, to amend the Public Health Service Act to increase the number of permanent faculty in palliative care at accredited allopathic and osteopathic medical schools, nursing schools, and other programs, including social work, physician assistant, and chaplaincy education programs, to promote education and research in palliative care and hospice, and to support the development of faculty careers in academic palliative and hospice care, S.2289, to amend titles XIX and XXI of the Social Security Act to improve maternal health coverage under Medicaid and CHIP, S.2323, to amend the Head Start Act to permit some teachers in Early Head Start programs to teach while earning a child development associate credential, S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.2531, to authorize the Secretary of Health and Human Services to award grants to increase early detection of and intervention for uterine fibroids, S.2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, S.2699, to amend the Public Health Service Act to reauthorize certain education and training programs relating to geriatrics, S.2762, to establish a commission on long-term care, S.2826, to direct the Secretary of Health and Human Services to dedicate sufficient resources for the support of LGBTQ+ youth seeking help from the 9-8-8 suicide prevention hotline, S.2828, to amend the Child Care and Development Block Grant Act of 1990 to reauthorize and update the Act, S.2833, to amend the Older Americans Act of 1965 to improve falls prevention research and activities, S.2841, to amend the American History and Civics Education program under the Elementary and Secondary Education Act of 1965 to require hands-on civic engagement activities for teachers

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Reported to Senate
Titles (2)
  1. Medication Affordability and Patent Integrity Act

    Short title, Display title · Reported to Senate, Introduced in Senate

  2. A bill to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.

    Official title · Introduced in Senate